Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Insulin allergy manifesting soon after COVID-19 vaccination (BNT162b2).
Komamura, Hiroshi; Kawana, Yohei; Imai, Junta; Katagiri, Hideki.
J Diabetes Investig ; 14(3): 498-499, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2266944

ABSTRACT

We experienced a case with insulin allergy which manifested soon after COVID-19 vaccination.


Subject(s)
COVID-19 , Hypersensitivity , Insulins , Humans , BNT162 Vaccine , COVID-19 Vaccines , Vaccination
2.
Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan.
Sato, Toshihiro; Kodama, Shinjiro; Kaneko, Keizo; Imai, Junta; Katagiri, Hideki.
Emerg Infect Dis ; 28(7): 1518-1520, 2022 07.
Article in English | MEDLINE | ID: covidwho-1809305

ABSTRACT

Recently, along with increasing use of immune checkpoint inhibitors such as nivolumab, the incidence of immune-related adverse events, including type 1 diabetes mellitus, has become a serious problem. We report a patient who had immune checkpoint inhibitor‒associated type 1 diabetes mellitus that developed after a second mRNA-based SARS-CoV-2 vaccination.


Subject(s)
COVID-19 Vaccines/adverse effects , COVID-19/prevention & control , Diabetes Mellitus, Type 1/chemically induced , Immune Checkpoint Inhibitors/adverse effects , Nivolumab/adverse effects , SARS-CoV-2/immunology , Humans , Japan , Vaccination/adverse effects
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL